Elcin Barker Ergun becomes Menarini CEO

After 8 years working in technology sector in the UK and the Netherlands, Elcin Barker Ergun entered the pharmaceutical industry with Smithkline Beecham as subsidiary CFO. She then joined Merck KGaA’s Healthcare business where she covered positions of increasing seniority with global business responsibilities as well as managing R&D collaborations in her last role heading New Business.

Elcin Barker Ergun is the ideal addition to the Menarini team, in order to  continue the agenda of growth  in geography and therapeutic areas, commented Eric Cornut, Chairman of Menarini.